Clinical trial
Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients
NCT00356187 is registered in ClinicalTrials.gov with Denver Health and Hospital Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients
- Lead sponsor
- Denver Health and Hospital Authority
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 15, 2006
- Completion date
- January 31, 2009
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
trauma